This product is intended for laboratory research use only.
Not for human or veterinary use.
Not approved for diagnostic, therapeutic, or medical applications.
Handle using appropriate laboratory safety procedures and personal protective equipment.
BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a naturally occurring protein in human gastric juice. The peptide was originally characterized by the Sikiric group at the University of Zagreb School of Medicine and has been investigated for over two decades in preclinical research models for its effects on tissue regeneration, angiogenesis, fibroblast migration, and cellular signaling across tendon, ligament, muscle, gastrointestinal, and vascular tissues. Research interest extends to nitric oxide system modulation, neuroprotection, and dopaminergic / serotonergic pathway interactions. BPC-157 is unusual among peptides for its reported stability against gastric proteolysis, a property attributed to its evolutionary origin in the digestive environment. The 10 mg lyophilized vial format supports subcutaneous research administration consistent with the bulk of published preclinical literature.
• Tendon and ligament research — studied for connective tissue regeneration endpoints in preclinical models
• Angiogenesis — investigated for new blood vessel formation and vascularization in healing tissues
• Gastric and intestinal protection — explored for mucosal integrity in NSAID-induced and stress-induced GI injury models
• Muscle regeneration — examined for satellite cell activation and skeletal muscle recovery research
• Cellular signaling — researched for fibroblast migration, collagen synthesis, and nitric oxide pathway modulation
• Angiogenesis and vascularization endpoints in soft tissue recovery models
• Fibroblast migration, collagen synthesis, and wound closure rates
• Gastrointestinal mucosal integrity in NSAID and stress-induced injury models
• Tendon-to-bone healing and ligament reconstruction in surgical research
• Neuroprotective and anti-inflammatory signaling in preclinical research
• Form: Lyophilized white powder
• Net Peptide Content: 10 mg per vial
• Quantity: 1 vial
• Appearance: White to off-white lyophilizate
• Reconstitution: Bacteriostatic or sterile water (added by the end researcher)
• Purity: ≥99% by HPLC
• Identity: MS-verified (per COA)
• Storage: Protect from light
• Compound: BPC-157 (Body Protection Compound-157)
• Synonyms: PL 14736; Pentadecapeptide BPC-157; Body Protection Compound 15
• Class: Synthetic pentadecapeptide; gastric juice–derived tissue regenerative peptide
• Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 amino acids)
• Formula / M.W.: C62H98N16O22, ~1419.55 g/mol
• CAS: 137525-51-0
⚠️ Disclaimer
COA Verification Notice: Even if the vial label or product image states a certain concentration, always go by the COA for the true verified value. We reference the COA to determine the verified concentration and purity of each product, regardless of what the label or product image indicates.
• BPC-157 Batch COA — September 18, 2025
This product has sterility testing
Every batch ships with a matching Certificate of Analysis. The batch number printed on your vial corresponds directly to its published certificate. Verify any batch on our Testing & COAs page.
Orders placed before 5 PM ET ship the same business day via Xpresspost. Most Canadian addresses receive delivery within 1–2 business days. Free shipping applies automatically on orders over $200.
Store refrigerated at 2–8 °C, protected from light. For laboratory research use only — not for human consumption.
This product is intended for laboratory research use only. Not
